dapsone has been researched along with Dermatitis Medicamentosa in 52 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dapsone has potent anti-inflammatory effects, and is used in the treatment of leprosy, cutaneous vasculitis, neutrophilic dermatoses, and dermatitis herpetiformis and other blistering disorders." | 7.75 | Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies. ( Chun, JS; Kim, SJ; Lee, JB; Lee, SC; Won, YH; Yun, SJ, 2009) |
| "We conclude that cholangitis, though unusual, can also form a part of dapsone syndrome." | 7.72 | Dapsone induced cholangitis as a part of dapsone syndrome: a case report. ( Choudhuri, G; Dhingra, S; Itha, S; Kumar, A, 2003) |
| "We report 3 cases of dapsone hypersensitivity syndrome due to anti-malarial chemoprophylactic treatment with maloprim, in military servicemen, presenting like a viral exanthem." | 7.72 | Dapsone hypersensitivity syndrome masquerading as a viral exanthem: three cases and a mini-review. ( Khoo, BP; Oh, HM; Poh, WT; Tee, AK; Wee, IY, 2004) |
| "Side-effects of leprosy treatment with dapsone are said to be uncommon, with drug allergy occurring in only one of every several hundred patients treated with dapsone." | 7.68 | Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy. ( Ala, J; Hall, JJ; Reeve, PA, 1992) |
| "All patients with the acquired immunodeficiency syndrome and a first episode of Pneumocystis carinii pneumonia seen at the San Francisco General Hospital between November 1984 and April 1985 were evaluated for oral treatment with dapsone (100 mg/d) plus trimethoprim (20 mg/kg body weight X d)." | 7.67 | Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. ( Hopewell, PC; Hughes, W; Leoung, GS; Mills, J; Wofsy, C, 1986) |
| "A 45-year-old woman developed hypersensitivity to dapsone when this drug was used to treat corticoid-dependent asthma." | 4.79 | [Hypersensitivity syndrome caused by dapsone. Transient circulating clone T]. ( Bocquet, H; Bourgault-Villada, I; Delfau-Larue, MH; Revuz, J; Roujeau, JC; Wechsler, J, 1995) |
| "Dapsone has potent anti-inflammatory effects, and is used in the treatment of leprosy, cutaneous vasculitis, neutrophilic dermatoses, and dermatitis herpetiformis and other blistering disorders." | 3.75 | Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies. ( Chun, JS; Kim, SJ; Lee, JB; Lee, SC; Won, YH; Yun, SJ, 2009) |
| "We conclude that cholangitis, though unusual, can also form a part of dapsone syndrome." | 3.72 | Dapsone induced cholangitis as a part of dapsone syndrome: a case report. ( Choudhuri, G; Dhingra, S; Itha, S; Kumar, A, 2003) |
| "We report 3 cases of dapsone hypersensitivity syndrome due to anti-malarial chemoprophylactic treatment with maloprim, in military servicemen, presenting like a viral exanthem." | 3.72 | Dapsone hypersensitivity syndrome masquerading as a viral exanthem: three cases and a mini-review. ( Khoo, BP; Oh, HM; Poh, WT; Tee, AK; Wee, IY, 2004) |
| "The 'dapsone syndrome' developed in a 44-year-old woman who was treated for pyoderma gangrenosum with 100 mg/day dapsone for about 5 weeks." | 3.69 | A case of the 'dapsone syndrome'. ( Ikezawa, Z; Kim, S; Miyamoto, H; Saito, S, 1994) |
| "Side-effects of leprosy treatment with dapsone are said to be uncommon, with drug allergy occurring in only one of every several hundred patients treated with dapsone." | 3.68 | Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy. ( Ala, J; Hall, JJ; Reeve, PA, 1992) |
| "All patients with the acquired immunodeficiency syndrome and a first episode of Pneumocystis carinii pneumonia seen at the San Francisco General Hospital between November 1984 and April 1985 were evaluated for oral treatment with dapsone (100 mg/d) plus trimethoprim (20 mg/kg body weight X d)." | 3.67 | Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. ( Hopewell, PC; Hughes, W; Leoung, GS; Mills, J; Wofsy, C, 1986) |
| "Dapsone was discontinued in nine (39%) patients because of adverse reactions." | 2.67 | Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals. ( Horowitz, HW; Jorde, UP; Wormser, GP, 1993) |
| "Dapsone is a sulfone drug used to treat infectious conditions and also numerous dermatologic diseases." | 2.55 | Dapsone-associated fixed drug eruption. ( Cohen, PR; Garcia, D, 2017) |
| " Once the patient's liver function normalized, prednisone dosage was reduced by 5 mg weekly." | 1.29 | Dapsone hypersensitivity syndrome. ( Prussick, R; Shear, NH, 1996) |
| " Dosage data indicated that fatalities had taken higher doses and continued prophylaxis after onset of symptoms." | 1.28 | Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. ( Phillips-Howard, PA; West, LJ, 1990) |
| "In a patient with subcorneal pustular dermatosis (SPD) the appearance of new pustular lesions characteristic of the disease was triggered by two episodes of drug eruption (induced by dapsone and quinidine sulphate respectively) and by the intra-dermal injection of the recall antigens Candida and streptokinase-streptodornase, performed for evaluation of delayed hypersensitivity." | 1.27 | Subcorneal pustular dermatosis--an unusual course. ( Feuerman, EJ; Halevy, S; Ingber, A, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (26.92) | 18.7374 |
| 1990's | 13 (25.00) | 18.2507 |
| 2000's | 13 (25.00) | 29.6817 |
| 2010's | 10 (19.23) | 24.3611 |
| 2020's | 2 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Thangaraju, P | 1 |
| Venkatesan, S | 1 |
| Morris, LM | 1 |
| Lewis, HA | 1 |
| Cornelius, LA | 1 |
| Chen, DY | 1 |
| Rosman, IS | 1 |
| Beshay, A | 1 |
| Petersen, M | 1 |
| Rhoads, JLW | 1 |
| Garcia, D | 1 |
| Cohen, PR | 1 |
| Belum, VR | 1 |
| Marchetti, MA | 1 |
| Dusza, SW | 1 |
| Cercek, A | 1 |
| Kemeny, NE | 1 |
| Lacouture, ME | 1 |
| Zhao, CY | 1 |
| Liu, RC | 1 |
| Consuegra, G | 1 |
| Hui, R | 1 |
| Fernandez-Penas, P | 1 |
| Tangamornsuksan, W | 1 |
| Lohitnavy, M | 1 |
| Gusdorf, L | 1 |
| Lipsker, D | 1 |
| Urosevic-Maiwald, M | 1 |
| Kerl, K | 1 |
| Harr, T | 1 |
| Bogdan Allemann, I | 1 |
| Narasimharao, P | 1 |
| Pratap, DV | 1 |
| Suneetha, S | 1 |
| Chun, JS | 1 |
| Yun, SJ | 1 |
| Kim, SJ | 1 |
| Lee, SC | 1 |
| Won, YH | 1 |
| Lee, JB | 1 |
| Chen, YC | 1 |
| Chiu, HC | 1 |
| Chu, CY | 1 |
| Santos, VM | 1 |
| Castro, RA | 1 |
| Lima, CC | 1 |
| Moraes, MB | 1 |
| Sugai, TA | 1 |
| Lorenz, M | 1 |
| Wozel, G | 1 |
| Schmitt, J | 1 |
| Itha, S | 1 |
| Kumar, A | 1 |
| Dhingra, S | 1 |
| Choudhuri, G | 1 |
| Labandeira, J | 1 |
| Toribio, J | 1 |
| COMBES, FC | 1 |
| SCOTT, MJ | 1 |
| BROWNE, SG | 3 |
| Tee, AK | 1 |
| Oh, HM | 1 |
| Wee, IY | 1 |
| Khoo, BP | 1 |
| Poh, WT | 1 |
| Merk, HF | 1 |
| Higuchi, M | 1 |
| Agatsuma, T | 1 |
| Iizima, M | 1 |
| Yamazaki, Y | 1 |
| Saita, T | 1 |
| Ichikawa, T | 1 |
| Kamijo, Y | 1 |
| Arakura, H | 1 |
| Hora, K | 1 |
| Kiyosawa, K | 1 |
| Agrawal, S | 1 |
| Agarwalla, A | 1 |
| Bhaiya, P | 1 |
| Roychowdhury, S | 1 |
| Vyas, PM | 1 |
| Doll, MA | 1 |
| Hein, DW | 1 |
| Svensson, CK | 1 |
| Sener, O | 1 |
| Doganci, L | 1 |
| Safali, M | 1 |
| Besirbellioglu, B | 1 |
| Bulucu, F | 1 |
| Pahsa, A | 1 |
| Peng, DD | 1 |
| Fang, JL | 1 |
| Wang, H | 1 |
| Wei, L | 1 |
| Halevy, S | 1 |
| Ingber, A | 1 |
| Feuerman, EJ | 1 |
| Sinha, MR | 1 |
| Talwat, EN | 1 |
| Alarcón, GS | 1 |
| Sams, WM | 1 |
| Barton, DD | 1 |
| Reveille, J | 1 |
| Revuz, J | 2 |
| Hornac, P | 1 |
| Tomecki, KJ | 1 |
| Catalano, CJ | 1 |
| Ree, GH | 1 |
| Kame, P | 1 |
| Stephen, G | 1 |
| George, O | 1 |
| Mathai, D | 1 |
| Kaur, A | 1 |
| Abraham, OC | 1 |
| Hiran, S | 1 |
| Pande, TK | 1 |
| Rizvi, SA | 1 |
| Vishwanathan, KA | 1 |
| Saito, S | 1 |
| Ikezawa, Z | 1 |
| Miyamoto, H | 1 |
| Kim, S | 1 |
| Jorde, UP | 1 |
| Horowitz, HW | 1 |
| Wormser, GP | 1 |
| Bocquet, H | 1 |
| Bourgault-Villada, I | 1 |
| Delfau-Larue, MH | 1 |
| Wechsler, J | 1 |
| Roujeau, JC | 1 |
| Noble, A | 1 |
| MacDonald, A | 1 |
| Prussick, R | 1 |
| Shear, NH | 1 |
| Friedman, IS | 1 |
| Rudikoff, D | 1 |
| Phelps, RG | 1 |
| Sapadin, AN | 1 |
| Cohen, DM | 1 |
| Bhattacharyya, I | 1 |
| Zunt, SL | 1 |
| Tomich, CE | 1 |
| Baxt, RD | 1 |
| Kong, LN | 1 |
| Reeve, PA | 1 |
| Ala, J | 1 |
| Hall, JJ | 1 |
| Chan, HL | 2 |
| Lee, KO | 1 |
| Phillips-Howard, PA | 1 |
| West, LJ | 1 |
| Grayson, ML | 1 |
| Yung, AP | 1 |
| Doherty, RR | 1 |
| Leoung, GS | 1 |
| Mills, J | 1 |
| Hopewell, PC | 1 |
| Hughes, W | 1 |
| Wofsy, C | 1 |
| Tham, SN | 1 |
10 reviews available for dapsone and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Dapsone-associated fixed drug eruption.
Topics: Anti-Infective Agents; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug Eruptions; Humans | 2017 |
Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-analysis.
Topics: Anti-Infective Agents; Dapsone; Drug Eruptions; Drug Hypersensitivity Syndrome; Genotype; HLA-B13 An | 2018 |
Neutrophilic urticarial dermatosis: A review.
Topics: Arthralgia; Colchicine; Cryopyrin-Associated Periodic Syndromes; Dapsone; Dermis; Diagnosis, Differe | 2018 |
Dapsone-induced erythema multiforme with neutropenia in a patient with linear IgA dermatosis: case report and review of the literature.
Topics: Anti-Inflammatory Agents; Dapsone; Dermatologic Agents; Drug Eruptions; Erythema Multiforme; Humans; | 2013 |
Hypersensitivity reactions to dapsone: a systematic review.
Topics: Dapsone; Drug Eruptions; Humans; Leprostatic Agents; Prevalence; Risk Factors | 2012 |
Reinstatement of dapsone following hypersensitivity.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatitis Herpetiformis; Diagnosis, D | 2003 |
[Pharmacogenetics: Important aspects for dermatology].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Dapsone; Dermatology; Drug Eruptions; Fluorou | 2005 |
[Side effects of treatment with sulfones].
Topics: Adult; Agranulocytosis; Chemical and Drug Induced Liver Injury; Child; Dapsone; Drug Eruptions; Drug | 1981 |
[Hypersensitivity syndrome caused by dapsone. Transient circulating clone T].
Topics: Anti-Asthmatic Agents; Asthma; Blotting, Southern; Clone Cells; Dapsone; Drug Eruptions; Drug Hypers | 1995 |
Captopril-triggered linear IgA bullous dermatosis.
Topics: Autoantibodies; Basement Membrane; Captopril; Dapsone; Drug Eruptions; Drug Therapy, Combination; Fe | 1998 |
2 trials available for dapsone and Dermatitis Medicamentosa
| Article | Year |
|---|---|
A prospective, randomized, double-blinded, split-face/chest study of prophylactic topical dapsone 5% gel versus moisturizer for the prevention of cetuximab-induced acneiform rash.
Topics: Acneiform Eruptions; Adult; Aged; Anti-Infective Agents; Antineoplastic Agents; Carcinoma, Squamous | 2017 |
Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals.
Topics: Adult; AIDS-Related Opportunistic Infections; Contraindications; Dapsone; Drug Eruptions; Female; Fe | 1993 |
40 other studies available for dapsone and Dermatitis Medicamentosa
| Article | Year |
|---|---|
A double blow for a patient with leprosy: a reversal reaction and an adverse drug reaction.
Topics: Adrenal Cortex Hormones; Adult; Dapsone; Drug Eruptions; Humans; Leprostatic Agents; Leprosy; Male | 2019 |
Neutrophil-predominant bullous pemphigoid induced by checkpoint inhibitors: A case series.
Topics: Aged; Antimalarials; Dapsone; Drug Eruptions; Drug Therapy, Combination; Glucocorticoids; Humans; Im | 2020 |
Severe EGFR inhibitor-induced acneiform eruption responding to dapsone.
Topics: Acneiform Eruptions; Afatinib; Aged; Carcinoma, Non-Small-Cell Lung; Dapsone; Drug Eruptions; ErbB R | 2021 |
Epidermal growth factor receptor inhibitor-induced papulopustular eruption successfully treated with low-dose oral dapsone.
Topics: Administration, Oral; Carcinoma, Non-Small-Cell Lung; Dapsone; Dose-Response Relationship, Drug; Dru | 2018 |
Acute Generalized Exanthematous Pustulosis (AGEP) due to dapsone in a patient with leprosy.
Topics: Acute Disease; Adult; Dapsone; Drug Eruptions; Humans; Leprostatic Agents; Leprosy; Male; Skin Disea | 2009 |
Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies.
Topics: Adult; Autoantibodies; Dapsone; Dermatologic Agents; Drug Eruptions; Female; Humans; Hypersensitivit | 2009 |
Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Anti-Infective Agents; Anticonvulsants; Chi | 2010 |
Skin eruption and thrombocytopaenia in a woman with glaucoma: a case report.
Topics: Anti-Infective Agents; Antihypertensive Agents; Biopsy; Dapsone; Drug Eruptions; Female; Glaucoma; H | 2010 |
Dapsone induced cholangitis as a part of dapsone syndrome: a case report.
Topics: Adult; Cholangitis; Dapsone; Drug Eruptions; Drug Hypersensitivity; Fever; Humans; Hyperbilirubinemi | 2003 |
Sulfoxone, diasone, sodium dermatitis; unusual distribution in a patient with leprosy.
Topics: Dapsone; Dermatitis; Drug Eruptions; Humans; Leprosy; Sodium; Sulfones | 1952 |
DESENSITIZATION FOR DAPSONE DERMATITIS.
Topics: Dapsone; Dermatitis; Desensitization, Immunologic; Drug Eruptions; Leprosy; Sulfones; Toxicology | 1963 |
POLYSENSITIVITY TO ANTI-LEPROSY DRUGS.
Topics: Dapsone; Drug Eruptions; Drug Hypersensitivity; Drug Resistance; Drug Resistance, Microbial; Humans; | 1964 |
FIXED ERUPTION IN DEEPLY PIGMENTED SUBJECTS: CLINICAL OBSERVATIONS ON 350 PATIENTS.
Topics: Black People; Congo; Dapsone; Diagnosis; Drug Eruptions; Drug Hypersensitivity; Exanthema; Leprosy; | 1964 |
Dapsone hypersensitivity syndrome masquerading as a viral exanthem: three cases and a mini-review.
Topics: Adolescent; Adult; Antimalarials; Dapsone; Diagnosis, Differential; Drug Combinations; Drug Eruption | 2004 |
A case of drug-induced hypersensitivity syndrome with multiple organ involvement treated with plasma exchange.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Drug Eruptions; Humans; Male; Middle Aged; Plasma | 2005 |
Dapsone hypersensitivity syndrome: a clinico-epidemiological review.
Topics: Adolescent; Adult; Anti-Infective Agents; Dapsone; Drug Eruptions; Female; Humans; Male; Middle Aged | 2005 |
Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts.
Topics: Anti-Infective Agents; Arylamine N-Acetyltransferase; Cells, Cultured; Dapsone; Dose-Response Relati | 2006 |
Severe dapsone hypersensitivity syndrome.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatitis Herpetiformis; Drug Eruptions; D | 2006 |
[Dapsone syndrome: a case report].
Topics: Adult; Dapsone; Drug Eruptions; Humans; Male; Syndrome | 2006 |
Subcorneal pustular dermatosis--an unusual course.
Topics: Aged; Dapsone; Drug Eruptions; Female; Humans; Quinidine; Skin; Skin Diseases | 1983 |
Fixed genital drug eruption due to dapsone. A case report.
Topics: Adult; Dapsone; Drug Eruptions; Female; Genital Diseases, Female; Humans; Leprosy; Recurrence | 1982 |
"Black spots" in Papua New Guinea Defence Force personnel: report of 12 cases.
Topics: Adolescent; Antimalarials; Dapsone; Drug Combinations; Drug Eruptions; Female; Humans; Male; Militar | 1983 |
Bullous lupus erythematosus rash worsened by Dapsone.
Topics: Adolescent; Blister; Dapsone; Drug Eruptions; Female; Humans; Lupus Erythematosus, Systemic | 1984 |
Dapsone hypersensitivity. The sulfone syndrome revisited.
Topics: Acne Vulgaris; Adolescent; Anemia, Hemolytic; Chemical and Drug Induced Liver Injury; Dapsone; Drug | 1981 |
Skin reactions to dapsone.
Topics: Adolescent; Adult; Child; Dapsone; Drug Eruptions; Female; Humans; Male | 1981 |
Dapsone syndrome.
Topics: Adult; Dapsone; Drug Eruptions; Drug Hypersensitivity; Female; Fever; Humans; Liver; Syndrome | 1994 |
Dapsone syndrome.
Topics: Adolescent; Adult; Dapsone; Drug Eruptions; Female; Humans; Leprosy, Borderline; Leprosy, Tuberculoi | 1994 |
A case of the 'dapsone syndrome'.
Topics: Adult; Dapsone; Drug Eruptions; Female; Humans; Pyoderma Gangrenosum; Skin | 1994 |
Drug-induced hepatotoxicity.
Topics: Antimalarials; Chemical and Drug Induced Liver Injury; Dapsone; Drug Combinations; Drug Eruptions; H | 1996 |
Dapsone hypersensitivity syndrome.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Chole | 1996 |
Linear IgA disease histopathologically and clinically masquerading as lichen planus.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatologic Agents; Diagnosis, Differential | 1999 |
Lepromatous leprosy with drug reaction.
Topics: Clofazimine; Dapsone; Drug Eruptions; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy | 2000 |
Cutaneous drug reaction case reports: from the world literature.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Aged; Amlodipine; Anti-Bacterial Agents; Anti-I | 2001 |
[Nursing care of epidermolysis bullosa drug eruption].
Topics: Adolescent; Adult; Carbamazepine; Dapsone; Drug Eruptions; Epidermolysis Bullosa Acquisita; Female; | 1992 |
Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Clofazimine; Dapsone; Drug Eruptions; Dru | 1992 |
Tonsillar membrane in the DDS (dapsone) syndrome.
Topics: Dapsone; Drug Eruptions; Female; Heinz Bodies; Humans; Leprosy, Tuberculoid; Middle Aged; Palatine T | 1991 |
Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Chemical and Drug Induced Liver Injury; Child; Child, | 1990 |
Severe dapsone syndrome due to weekly maloprim.
Topics: Adult; Antimalarials; Dapsone; Drug Combinations; Drug Eruptions; Female; Humans; Lymphatic Diseases | 1988 |
Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Bronchoscopy; Dapsone; Drug Eruptions; Drug Therapy, Combination | 1986 |
Fixed drug eruptions to maloprim.
Topics: Adult; Antimalarials; Dapsone; Drug Combinations; Drug Eruptions; Humans; Male; Pyrimethamine; Skin | 1988 |